维普中文期刊产品整合服务

Post-transplantation lymphoproliferative disorders:Current concepts and future therapeutic approaches

查看全文 作  者:Fedaey [1,2]Abbas;Mohsen El [2,3]Kossi;Ihab Sakr [2,4]Shaheen;Ajay [2,5]Sharma;Ahmed [2,6]Halawa 高影响力作者 机构地区:[1]Nephrology Department,Jaber El Ahmed Military Hospital,Safat 13005,Kuwait;[2]Faculty of Health and Science,University of Liverpool,Institute of Learning and Teaching,School of Medicine,Liverpool L693GB,United Kingdom;[3]Doncaster Royal Infirmary,Doncaster DN25LT,United Kingdom;[4]Department of Paediatric Nephrology,Royal Hospital for Children,Glasgow G514TF,United Kingdom;[5]Department of Transplant Surgery,Royal Liverpool University Hospitals,Liverpool L78XP,United Kingdom;[6]Department of Transplantation,Sheffield Teaching Hospitals,Sheffield S57AU,United Kingdom高影响力机构 出  处:《World Journal of Transplantation》索引2020年第10卷第2期,共18页高影响力期刊 摘  要:Transplant recipients are vulnerable to a higher risk of malignancy after solid organ transplantation and allogeneic hematopoietic stem-cell transplant.Posttransplant lymphoproliferative disorders(PTLD)include a wide spectrum of diseases ranging from benign proliferation of lymphoid tissues to frank malignancy with aggressive behavior.Two main risk factors of PTLD are:Firstly,the cumulative immunosuppressive burden,and secondly,the oncogenic impact of the Epstein-Barr virus.The latter is a key pathognomonic driver of PTLD evolution.Over the last two decades,a considerable progress has been made in diagnosis and therapy of PTLD.The treatment of PTLD includes reduction of immunosuppression,rituximab therapy,either isolated or in combination with other chemotherapeutic agents,adoptive therapy,surgical intervention,antiviral therapy and radiotherapy.In this review we shall discuss the prevalence,clinical clues,prophylactic measures as well as the current and future therapeutic strategies of this devastating disorder. 关 键 词:Lymphoproliferative disorders Epstein-Barr virus Solid organ transplant Hematopoietic stem cell transplant Post-transplant lymphoproliferative disorder prevention Future therapies
相关文献

参考文献(104)

引证文献(11)

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费